Stem cell transplants offer significant hope for brain repair following ischemic damage. Pre-clinical work suggests that therapeutic mechanisms may be multi-faceted, incorporating bone-fide circuit reconstruction by transplanted neurons, but also protection/regeneration of host circuitry. Here, we engineered hydrogel scaffolds to form ''bio-bridges'' within the necrotic lesion cavity, providing physical and trophic support to transplanted human embryonic stem cell-derived cortical progenitors, as well as residual host neurons. Scaffolds were fabricated by the self-assembly of peptides for a laminin-derived epitope (IKVAV), thereby mimicking the brain's major extracellular protein. Following focal ischemia in rats, scaffold-supported cell transplants induced progressive motor improvements over 9 months, compared to cell-or scaffold-only implants. These grafts were larger, exhibited greater neuronal differentiation, and showed enhanced electrophysiological properties reflective of mature, integrated neurons. Varying graft timing post-injury enabled us to attribute repair to both neuroprotection and circuit replacement. These findings highlight strategies to improve the efficiency of stem cell grafts for brain repair.
In Brief Somaa et al. examine the capacity of peptide-based scaffolds to structurally and functionally support human pluripotent stem cell-derived neural transplants in the stroke-injured brain. Scaffolds promoted graft maturation and integration and reduced host tissue atrophy, resulting in improved motor function over a period of 9 months.
INTRODUCTION
Loss of neurons in the cerebral cortex underlies much of the motor, sensory, and cognitive dysfunction in stroke patients, with disability due to primary neuronal loss, as well as additional ongoing secondary degeneration in the surrounding penumbra . With the exception of surgical clot removal or thrombolytic drugs, both targeted at restoring perfusion and penumbral protection, no effective treatment is currently available to improve functional recovery in patients . Circuit replacement, through transplantation of neural progenitor cells (NPCs) generated from pluripotent stem cells (PSCs), represents a hopeful and realistic therapeutic strategy.
Clinical proof-of-principle for this approach is drawn from Parkinson's disease patient trials where transplanted dopamine neurons reinnervate the denervated striatum, resulting in sustained improvement of motor function (Barker et al., 2013) . A fundamental requirement for therapeutic efficacy is the correct specification of transplanted neurons in order to facilitate functional innervation of appropriate targets (Thompson and Bjö rklund, 2012) .
For acute brain injuries, including ischemic stroke, the requirement for functional connectivity is less clear. Pre-clinical studies have demonstrated therapeutic benefits associated with transplant-mediated effects on host tissue including penumbral protection, enhanced angiogenesis, modulation of inflammation, and stimulation of compensatory plasticity . This has stimulated interest in the use of non-neural cells, such as mesenchymal stem cells, as donor-cell preparations aimed squarely at conferring benefit through these homeostatic mechanisms (Cao and Li, 2015) . While promising, functional recovery is often incomplete and may be limited by extensive nonrecoverable damage. Thus, additional functional recovery through bona-fide circuit reconstruction remains a promising strategy.
PSCs hold significant potential as a donor source for cell replacement in stroke. Routine procedures now exist for generating a diverse range of neuronal subtypes, including specification into cortical projection neurons (Shi et al., 2012; Chambers et al., 2009 ) relevant for replacement of cortical circuitry damaged after stroke. Following transplantation, PSC-derived neurons exhibit a remarkable capacity for long-range anatomical integration and development of appropriate electrophysiological properties (Denham et al., 2012; Espuny-Camacho et al., 2013; Niclis et al., 2017b; Steinbeck et al., 2012) . In rodent models of stroke, various degrees of functional recovery have been reported (Daadi et al., 2008; Gomi et al., 2012; Jensen et al., 2013; Jiang et al., 2011; Oki et al., 2012; Qin et al., 2013; Tatarishvili et al., 2014; Tornero et al., 2013) , but over time frames inconsistent with functional maturity of implanted neurons.
Thus, direct contribution to functional neuronal replacement has been difficult to assess.
Long-term survival and integration of grafted neurons may be particularly challenging in a stroke-affected hostile environment characterized by a cystic cavity, highly vulnerable peri-infarct tissue, and proinflammatory cues (Jendelová et al., 2016) . Use of biomaterials is increasingly being recognized as a valuable adjunct approach for cell-based therapies and may impart physical and trophic support to both host and grafted cells (Jendelová et al., 2016) . A variety of natural and synthetic polymers, such as collagen, chitosan, and poly(lactic acid), as well as decellularized scaffolds, have been employed to support neural grafts in the ischemic brain (Bible et al., 2009 (Bible et al., , 2012 Cheng et al., 2013; Elias and Spector, 2012; Jin et al., 2010; Liang et al., 2013; Park et al., 2002; Yu et al., 2010; Zhong et al., 2010) . While these materials have shown variable anatomical and functional benefits, most optimal for regenerative medicine will be the employment of readily injectable nanomaterials that self-assemble from biologically active molecules. Few studies have examined the potential for synthetic, but biomimetic, self-assembling peptide (SAP) scaffolds with transplantation and have focused on endogenous neuron survival and plasticity (Ellis-Behnke et al., 2006; Guo et al., 2009 ). Here, we report the use of an injectable biological substrate that facilitates long-term survival and functional maturation of human PSC (hPSC)-derived cortical neurons, when implanted into the site of cortical ischemic. We report this functionalized scaffold restored tissue architecture within the lesion cavity, reduced atrophy and cell loss within the penumbra, while additionally supported cortical neuronal differentiation of human PSC grafts. Scaffold-supported transplants were capable of prolonged restoration of motor function, providing evidence of sustained benefits of human stem cells and biomaterials in repair of the ischemic brain.
RESULTS

Characterization of Peptide-Based Scaffolds and Stem Cell Differentiation
To rebuild the local architecture at the primary injury site and support the integration of grafts into the surrounding host tissue, we tailored a biomaterial to provide structural scaffolding and biomimetic of the brain's extracellular matrix. The synthesized scaffold incorporated the laminin binding domain peptide sequence, IKVAV, necessary for neural adhesion, migration, differentiation, and axonal plasticity (Matson et al., 2011) . SAPs were optimized for assembly at pH 7.4, by adjustment of the pKa, through the addition of two aspartate residues, giving the resultant peptide sequence DDIKVAV ( Figure 1A ). Aromatic fluorenylmethyloxycarbonyl (Fmoc) moieties were used to protect the amino terminus of the peptide and provide shared electrons to form p-p interactions, creating a backbone structure (Figures 1A and 1B, red) . The individual peptides interacted via hydrogen bonds to form secondary protein b sheets ( Figure 1C ), confirmed by spectroscopic analysis (Figures 1F and 1G ). Through a combination of amphiphilic organization, p-p interactions, and b sheets, nanotubes were formed ( Figure 1D ) that interacted to create highly hydrated bundles and provided the underlying matrix ( Figure 1E ). Nanofibrous structure was confirmed via electron microscopy ( Figure 1H ), while rheological analysis validated viscoelastic gel properties, demonstrating that the resultant hydrogel had a modulus not dissimilar to the rat brain ( Figure 1I ) and was thereby suitable for brain repair.
Cortical progenitors were generated via dual SMAD inhibition of hPSCs, resulting in neural induction and dorsal forebrain specification, as shown by the presence of rosettes and neural-ridge structures at 10 days in vitro (DIV) and expression of the NPC marker SOX2, dorsal telencephalic marker PAX6, and forebrain/midbrain transcription factor OTX2 ( Figures 1J and  1K ). These forebrain progenitors, expanded as neurospheres, showed maintained GFP, OTX2, and Nestin expression at the time of transplantation ( Figures 1L and 1M , 17 DIV).
SAP-Supported Neural Grafts Improve Sensorimotor Function in Ischemic Rats
Staircase testing of fine and coordinated forelimb sensorimotor function was performed in rats receiving unilateral intracortical ischemic insults and cell ± SAP implants at 3 weeks ( Figure 2A ). ET1-lesioned rats showed a reduced proportion of pellets eaten with the impaired (left) paw, compared to saline-injected controls ( Figure 2A , intact, white triangles), prior to grafting, a deficit that remained persistent and stable for 36 weeks (Figure 2A , gray triangles). Limb use was significantly improved in ET1 rats receiving cell implants (ET1 + cells: 33.8 ± 2.4%; Figure 2A , gray circles) at 36 weeks compared to controls (ET1: 22.4 ± 2.3%) and notably more rapid in animals grafted with cells and scaffolds (ET1 + cells+SAP), with significant improvements observed as early as 16 weeks (33.9 ± 2.4%; Figure 2A , black circles). By 36 weeks cells+SAP implants continued to provide a significant benefit (41.3 ± 1.3%), with limb function not different from intact controls (41.7 ± 2.9%) and significantly greater than observed for cells alone. Note that SAP implants, in the absence of cells, provided no significant benefit for forelimb function, (26.0 + 3.1%; Figure 2A, white circles) .
Prior to killing animals for histology, additional motor function tests were performed. The rotarod test, a measure of balance, coordination, and physical condition (particularly of the hindlimbs), revealed no gross motor impairment resulting from ischemia at 36 weeks ( Figure 2B ). In the cylinder test, a measure of bias in limb use, ET1 and ET1 + SAP-implanted animals showed a significant impairment in contralateral forelimb use, reflected by reduced weight-bearing left forepaw touches on the cylinder wall, compared to saline-injected controls ( Figure 2C ). Only ischemic animals receiving cells+SAP grafts showed a significant improvement in left paw use compared to ET1-lesioned rats (52.1 ± 5.5% and 26.5 ± 4.7% wall touches using left paw, respectively), function that was not statistically separable from intact controls (51.8 ± 2.5%). The adjusted stepping test highlighted forelimb akinesia in ET1-lesioned animals, as revealed by significant reductions in left paw forehand and backhand touches at 36 weeks, that was partially restored only in animals receiving cells+SAP transplants ( Figures 2D and 2E ).
SAP Scaffolds Provide Structural and Biochemical Support for Transplanted Cortical Progenitors in the Ischemic Brain
At 36 weeks after receiving implants into the ischemic cortex, the majority of animals were taken for histological analysis. Human , and thereby maintained a cellular density similar to cellonly transplants, yet were visibly greater in density than the host cortex ( Figures 3E-3G ).
To characterize morphological properties of grafts, examination of neural markers together with GFP immunoreactivity was performed. Reflective of the ability of grafted cells to integrate into the host tissue, and not be impeded by either the scaffold or host scar tissue, numerous doublecortin migrating neuroblasts (DCN + GFP + ) were observed at the edge of the grafts and within the surrounding host parenchyma ( Figure 3K 3N , and 3O).
We also assessed grafts for the presence of cortical layer selective neuronal populations including the T box transcription factor, TBR1 (deep layers V-VI) and POU homeodomain protein, BRN2 (superficial layers II-IV) (Shi et al., 2012) . As a proportion of total neurons, cell grafts contained 37.6 ± 11.2% BRN2 and 7.4 ± 1.1% TBR1 neurons, while cells+SAP grafts contained a significant increase in the proportion of both BRN2 (65.8 ± 4.4%) and TBR1 (20.0 ± 2.7%) neurons (Figures 3I, 3J, and 3P-3S), suggesting the SAP scaffold impacted on the neuronal differentiation and phenotype acquisition of the progenitors in situ. Furthermore, in both cell and cells+SAP grafts, a dense network of vesicular glutamate transporter (VGLUT + ) glutamatergic fiber innervation could be observed ( Figure 3T ). Other neuronal populations were relatively sparse or absent, including g-aminobutyric acid (GABA) ( Figure 3T ), tyrosine hydroxylase (TH), 5HT, and choline acetyltransferase (ChAT) (data not shown). Interestingly, motor performance in the staircase test at 36 weeks correlated with graft volume, total cells within the graft (GFP + DAPI + ), and proportion of neurons (including cortical subpopulations), with those animals receiving cells+SAP implants (3 weeks after ET1 administration) displaying the greatest functional improvement and largest grafts with greatest neuronal proportions ( Figure S2 ) (related to Figures 2 and 3) .
Graft integration was assessed at 36 weeks after implantation by the presence and density of GFP + fibers with the surrounding host parenchyma. No discernable difference was observed in the pattern of axonal growth between cells and cells+SAP-implanted animals, with GFP + axonal projections observed emanating from the graft and extending long distances both rostro-caudally and dorso-ventrally from the site of implantation ( (legend continued on next page) layers II-V cortical projection neurons. Networks of GFP + fibers were also observed in subcortical nuclei, including the hippocampus, lateral septum, striatum (Figures 4E, 4Bv, and 4Bvi) , and more sparsely in the ventral thalamus and hypothalamus (Figures 4Cii and 4Ciii) . Densitometric analysis of GFP-labeled fibers in the motor cortex adjacent to the graft, and at distal cortical target sites (ipsi-and contralateral entorhinal cortex), confirmed the similarity in innervation density between cell and cell + SAP grafts ( Figure 4F ).
Cortical Progenitor Grafts Are Highly Vascularized and Show No Evidence of Neural Overgrowth 9 Months after Transplantation
Necessary for the survival of transplanted neurons is their close association to a vascular supply, with reports of neurons surviving poorly at distances greater than 75 mm from the nearest blood vessel (Casper et al., 2003) . In light of the large size of the hESC-derived cortical progenitor grafts observed, we examined the extent to which the new tissue was vascularized. RECA-1 immunostaining revealed a dense network of blood vessels in both cells and cells+SAP grafts (Figures 5A and 5B) that was not dissimilar between the two graft groups. Vessels within grafts were significantly hypertrophied compared to the host cortex (vessel diameter, host cortex: 18.6 ± 0.4 mm, cells graft: 35.5 ± 1.7 mm, cells ± SAP graft: 36.5 + 0.6 mm), lower in density (area covered by RECA1 + in the host cortex: 25.4 ± 0.8%; cell graft: 14.5 ± 1.5% and cells+SAP graft: 13.9 ± 0.7%; Figure 5C ), and likely reflect immature vessel formation and/or a feature of vascularization of human verse rodent tissue. Closer examination revealed that RECA1 + vessels within the grafts were GFP À ( Figure 5D ') and thus host-derived. In addition,
we observed extensive RECA1 + staining of vessels within the host tissue surrounding the graft (32.3 ± 0.4%), significantly greater than in the cortex of unlesioned animals, and indicative of important revascularization of the penumbra (Figures 5B'' and 5C). While hESCs were pre-differentiated in vitro and showed high neural composition within the grafts (including cortical identity) at 9 months, we importantly observed no gross morphological features within the grafts suggestive of excessive cell division or tumors. At 9 months, less than 0.5% of cells were dividing (Figures 5E-5G, %Ki67/DAPI), with only occasional small Ki67 + clusters observed within the grafts, that were often GFP À and localized around RECA1 + vessels ( Figure 5D ''), indicative of host involvement in vascularization of the new tissue.
A challenge working with athymic nude rats over extended periods of time, particularly where excessive handling is involved (such as for repeat surgeries and behavioral testing) is their susceptibility to pathogens. Consequently, during the course of the study a small number of animals were euthanized prior to 36 weeks due to unrelated skin and intestinal-related health concerns. These animals provided important insights into the growth kinetics of grafts. Irrespective of graft age, and despite the steady increases in graft volume over time (Figures S3A, related to Figure 5 ), no OCT4 + cells were observed in any animals (data not shown). Evident within younger grafts, however, was the trend toward an increased proportion of Ki67 + dividing cells within cells+SAP grafts at 5-7 months compared to cells alone ( Figure S3B ), suggesting that the scaffold may contribute to prolonging proliferation of the neuronal progenitor pool, a role recently attributed to IKVAV signaling (Sahab Negah et al., 2016) .
Human ESC-Derived Neurons, Grafted with SAP Scaffolds, Develop Functional Electrophysiological Properties in the Ischemic Cortex To determine whether grafted cells behaved as functionally connected neurons, brain slices from cells and cells+SAP-implanted animals were taken for eletrophysiological analysis. Native GFP fluorescence allowed for rapid identification of grafted cells (Figure 6Ai ) that were patched for whole-cell recordings under Dodt contrast (Figure 6Aii ). Interestingly, SAP fibers were visible within the slices, indicating maintained integrity of the SAP scaffold gel at 9 months (Figure 6Aii ). Patch-clamped cells were depolarized via current injections to activate voltage-activated channels if present. Various spiking patterns were noted in both cells and cells+SAP-grafted tissue ( Figures 6D and 6E) , including regular firing, fast spiking (Figure 6Di ), and intermittent bursting (Figure 6Dii) . Supported by reduced neuronal differentiation seen in cells-only grafts were responses indicative of no voltage-activated channel expression (Figure 6Diii ), a feature of immature neurons and astrocytes. For neurons in both graft types, action potential firing patterns were similar across various neuronal types ( Figure 6F ). Cells exhibited resting membrane potentials as follows: cell-only grafted neurons (À68 ± 2 mV, n = 5), cellonly grafted ''immature neurons/astrocytes'' (À74 ± 2 mV, n = 4), and cells+SAP-grafted neurons (À61 ± 2 mV, n = 7). In voltage clamp, we assessed pre-synaptic connectivity to neurons by recording both spontaneous excitatory and inhibitory post-synaptic currents ( Figure 6G ). In cell-only grafts, 4/5 recorded cells exhibited excitatory post-synaptic currents (EPSCs), while 3/5 exhibited inhibitory PSCs (IPSCs), suggesting not all neurons possessed excitatory and inhibitory inputs. In contrast, all neurons recorded from cells+SAP grafts exhibited both EPSPs and IPSCs. The frequency and amplitude of EPSCs and IPSCs across ''connected'' neurons were similar for cells and cells+SAP grafts, with robust and active functions noted ( Figure 6G ).
Cell Transplants in the Presence of SAP Scaffolds
Reduced Cortical Atrophy, an Effect That Was Enhanced by Acute Implantation after Ischemic Insult Cortical volume was assessed in all animals to determine the benefit of cell ± SAP implants in protecting against secondary degeneration of the host tissue. In a small cohort of animals killed 1week after ET1 injection, the primary insult was evident by the presence of a large necrotic lesion cavity within the sensorimotor cortex ( Figure 7E ), surrounded by acellular tissue (Figure 7E') , that without intervention resulted in significant secondary degeneration (32.9 ± 2.1% cortical atrophy; Figures 7A and 7F ) by 36 weeks. SAP implants alone minimally protected against atrophy of the host tissue (28.3 ± 2.6%; Figures 7A and 7G) . By contrast, cell grafts protected the penumbral tissue and significantly reduced atrophy (ET1 + cells, 18.6 ± 1.9%; Figures 7A  and 7H ), an effect that was greatest in cells+SAP-grafted animals (11.4 ± 1.3% cortical atrophy; Figures 7A and 7I ). In support of the graft-induced protection of the host penumbra, a strong correlation (r2 = 0.858) was observed between staircase performance and cortical atrophy ( Figure 7B ). (Ai and D) GFP fibers were observed throughout the rostro-caudal plane reaching targets as far rostral as the olfactory bulb and nucleus accumbens (Ai) and as caudal as the midbrain (D).
(Bi-Biii) GFP fibers were additionally seen throughout the dorso-lateral axis of the brain, with density greatest within the ipsilateral host cortex, including the motor (Bi), sensorimotor (Bii), and cingulate cortex, yet bundles of GFP + fibers were also observed coursing through forceps minor to innervate ventral cortical nuclei (Biii).
(Biv and Ci) Dense bundles of GFP + fibers were observed traversing the corpus callosum (Ci) to innervate the contralateral hemisphere, where similar patterns of cortical innervation, albeit fewer in density, were observed (Biv).
(Bv, Bvi, Cii, Ciii, and E) GFP fibers were additionally observed within subcortical nuclei including the lateral septum (Bv), striatum (Bvi), hippocampus (E), thalamus (Cii), hypothalamus (Ciii), and midbrain (Di).
(F) Density of graft-derived GFP + fibers within the host brain, proximal (MCtx) and distal (Ent Ctx, ipsilateral, I, and contralateral, C) to the site of implantation, revealed no difference in patterns or density of innervation between cells and cells+SAP grafts. Mean ± SEM, Student's t tests. Scale bars, 100 mm. NAc, nucleus accumbens; MCtx, motor cortex; SCtx, somatosensory cortex; EntCtx, enthorinal cortex; Thal, thalamus; CPu, striatum; CC, corpus callosum; HPC, hippocampus; MB, midbrain; hypothal, hypothalamus. Scale bars, 1 mm (A-D) and 100 mm (higher magnification insets).
While the majority of animals received transplants (cells ± SAP) at 3 weeks post-ET1 lesioning to assess the impact on functional integration and neuroprotection, an additional cohort of animals received implants at 6 days following ET1 administration in an effort to intervene earlier in protection against secondary degeneration and reduce cortical atrophy. Earlier intervention (at 6 days) provided no further protection against atrophy compared to later transplantation (at 3 weeks) for either SAP or cell-grafted animals ( Figures 7A, 7G , 7H, 7J, and 7K). However, early implants of cells+SAP significantly reduced atrophy (4.9 ± 0.8%) compared to intervention at 3 weeks ( Figures 7A, 7I , and 7L). Note, graft volume and cellular composition did not significantly vary between the two implantation times for either cells or cells+SAP grafts (data not shown).
At 36 weeks after implantation, we quantified groups for the density of cells within the host cortex to assess whether loss of cortical volume correlated with neuronal loss. Within a pre-determined area adjacent to the lesion site ( Figures 7D', F' , K', and L'), NEUN + neuronal density remained unchanged in saline and ET1-treated rats ( Figure 7C ), indicating atrophy was proportionate to cell loss. NEUN density within the host cortex was elevated in cells and cells+SAP-transplanted animals, suggesting that atrophy of the cortex was greater than the proportion of cell loss ( Figure 7C ).
DISCUSSION
Promoting repair following ischemic stroke will require targeted tissue engineering, including replacement cells, a substratum to support the integration of new cells, protection of the surrounding host, and revascularization of new and old tissue. Here, we report that a tissue-customized self-assembling peptide-based scaffold was capable of interfacing with both replacement neurons generated from human stem cells and residual host tissue, thereby creating a de novo tissue that induced sustained functional recovery in an animal model of focal ischemia. Numerous biomaterials have been developed to model the native three-dimensional environment of neural tissue, including both natural and synthetic polymers assembled as nanofibers, microspheres, or hydrogels. Such biomaterials have been demonstrated to promote the survival, proliferation, differentiation, and connectivity of neural cells in vitro (see review Rodriguez et al., 2012 ), yet have been decidedly more difficult to deploy and assess in vivo due to their bulkiness and lack of biocompatibility. Here, we demonstrate the practical utility of a SAP scaffold that post-injection presents IKVAV in a nanofibrous gel, while maintaining a modulus similar to the rat brain, and is capable of supporting cell adhesion and axonal growth in vivo. Delivery of the biomaterial directly into the lesion cavity provided an advantage over implantation into the already vulnerable surrounding host penumbral tissue, which could lead to iatrogenic complications. Within the injured brain, these scaffolds formed de novo ''bio-bridges'' between the lesion cavity, implanted cells, and host tissue. While scaffolds alone showed minimal protection of host tissue and function, advantages of the scaffolding were evident in conjunction with stem cell grafts, resulting in larger, more differentiated transplants than implants of cells alone. In addition to the structural support provided by the scaffold nanofibrils, which likely contributed to improved graft survival and integration, were the benefits of tissue-specific scaffold presentation of the functional laminin epitope, IKVAV. Previous studies have reported IKVAV, the motif from the a1 chain of the laminin-1 peptide sequence, promotes neuronal cell attachment, migration, differentiation, and neurite outgrowth (Cheng et al., 2013; Silva et al., 2004; Tashiro et al., 1989) , including that of hESC-derived neurons (Ma et al., 2008) . In support, here, we report enhanced neuronal specification of hESC-derived neural grafts in the presence of the IKVAV scaffold, as well as augmented deep (TBR1) and superficial (BRN2) cortical layer specification of NPCs, necessary for the replacement of neurons lost to the primary insult. Despite the generation of cortical subpopulations and presence of laminin signaling in the present study, no evidence of lamination was observed. This has been a common issue for cortical transplants into both the intact or infarcted cortex and likely reflects the absence of pial and ventricular surfaces, as well as radial glial cells. Such observations highlight room for further refinement of scaffolds in an effort to recreate such organized structures within the lesion cavity. A key attribute of the present study was the employment of ubiquitously expressing GFP human ESC-derived NPCs for transplantation, enabling detailed, protracted (9 month) assessment of graft composition and integration into the ischemic brain and in the presence of a biological scaffold. The constitutive GFP reporter line enabled detailed assessment of fiber growth patterns from the graft into the surrounding host tissue. Similar to previous reports of hPSC-derived cortical progenitors into the intact brain (Denham et al., 2012; Espuny-Camacho et al., 2013; Niclis et al., 2017b; Steinbeck et al., 2012) , and showing little difference in patterns of innervation between cells and cells+ SAP implants, fiber growth closely mimicked the intrinsic projections of the adult brain. Dense GFP innervation was observed most notably within the ipsi-and contralateral cortex, yet axons additionally extended through the external and internal capsule to distal caudal sites, consistent with replacement of lost cortical connections. Further studies will be required to determine the nature of functional synaptic connectivity in these remotely innervated brain regions. However, it is reasonable to speculate synaptic connectivity as a likely outcome, given recent monosynaptic tracing and electron microscopy studies demonstrating this as a property of transplanted neurons generated from pluripotent stem cells (Doerr et al., 2017; Grealish et al., 2015) .
Reflective of the morphological differences observed in the hESC-derived grafts in the absence and presence of the scaffold (notably graft size and cortical fate) was graft function. Electrophysiological recordings from cells+SAP-implanted animals revealed all recorded cells were functional neurons and demonstrated a higher degree of synaptic connectivity than grafts of cells alone, as evident by the presence of both inhibitory and excitatory inputs. In support of these findings, cells+SAP-implanted animals showed greater improvements in motor function and/or more rapid restoration of deficits than for animals receiving cell-only implants.
Mechanisms underlying the improvement in graft function remain a key question in cell-based therapy for repair of the ischemic brain. To what extent do transplanted cells provide replacement neurons verses trophism and protection of the host tissue? Observations of improved motor function as early as 8 weeks post-implantation, in both cells and cells+SAP-grafted animals, likely reflect trophism and is supported by the reduction in host cortical atrophy, notably the enhanced protection induced by earlier intervention. Additional functional improvement manifested between 16 and 36 weeks after grafting, particularly in the cells+SAP group. This is a time frame consistent with extensive axonal outgrowth and electrophysiological maturity observed in other grafting studies (Denham et al., 2012; Espuny-Camacho et al., 2013; Niclis et al., 2017b; Steinbeck et al., 2012) , and was complemented by correlative increases in graft size and neuronal (including cortical layer specific) differentiation, and likely reflect functional integration of implanted neurons as a contributing therapeutic mechanism. More detailed studies, employing engineered stem cell lines that can be silenced (by expressing light sensitive halorhodopsin or designer receptors exclusively activated by designer drug proteins), that have confirmed functional graft integration in Parkinson's disease (Chen et al., 2016; Steinbeck et al., 2015) , will be required to quantitate relative contributions from cell replacement and/or neuroprotection. On balance, it is important to understand the appropriate timing of transplantation after stroke to ensure maximal survival, integration, and function. Unlike previous reports (Darsalia et al., 2011) , only in animals receiving cell grafts in the presence of the SAP scaffold was early intervention advantageous, baring no impact on graft composition, but importantly enhancing protection of the penumbra and highlighting the importance of timing as a determinant of outcome for cell-based approaches to ischemic injury.
In summary, we report here long-term survival, integration, and therapeutic efficacy of neural grafts embedded in a selfassembling scaffold matrix after acute implantation into the ischemic cortex. The results show that the use of a readily injectable biomaterial provides significant advantage over cells alone when targeting the hostile environment presented by the strokeaffected tissue and additionally facilitates the survival and maturation of implanted neurons, as well as promotes substantial axonal outgrowth. Although acute neuroprotection appears to be the major contributing mechanism to recovery of motor function, the anatomical patterns of connectivity revealed by GFP + fiber outgrowth and the functional maturation of implanted cells suggest that functional replacement of cortical circuitry is an attainable goal as an additional source of therapeutic benefit.
EXPERIMENTAL PROCEDURES
Preparation of Self-Assembling Peptide Scaffolds A tissue-specific SAP for the brains major extracellular matrix (ECM) protein, laminin, was made using solid phase peptide synthesis (SPPS), as previously described (Rodriguez et al., 2013) . In brief, peptide synthesis was achieved by the stepwise deprotection of the N-terminal Fmoc group of the resin-anchored amino acid, followed by a coupling step. Two aspartate residues were incorporated at the N terminus of the peptide to lower the pKa and enable assembly under physiological conditions (pH 7.4). This process of deprotection and coupling of amino acids was repeated until the desired laminin-based epitope was synthesized, aspartate-aspartate-isoleucine-lysine-valine-alanine-valine (DDIKVAV; Figure 1A ). Fourier transform infrared (FTIR), circular dichroism (CD) spectroscopy, electron microscopy, and rheology were performed as previously described to verify synthesis, structure, and modulus of the peptide and resultant gel (Rodriguez et al., 2013 (Rodriguez et al., , 2014 . On day of use, Fmoc-SAP powder was dissolved to 20 mg/mL in deionized water and pH corrected to 7.4. At time of implantation, the gel underwent mechanical sheering and was mixed 1:1 with Hank's balanced salt solution (HBSS) or cells.
Differentiation of Human Embryonic Stem Cells
The human ESC line, HES3-ENVY, constitutively expressing GFP under the human b-actin promoter (Costa et al., 2005) ,was cultured and differentiated using a dual SMAD dorsal forebrain differentiation protocol, as previously described (Denham et al., 2012) . After 17 days, neurospheres were either (1) cryopreserved and sectioned for immunohistochemical analysis or (2) dissociated (Accutase, Invitrogen) to provide a single cell suspension (100,000 cells/mL). At the time of implantation, cells were diluted 1:1 in the hydrogel or HBSS media to a final density of 50,000 cells/mL. ) nude rats under general anesthetic (2% isoflurane). Focal ischemia was modeled in 109 rats by unilateral injections (2 3 0.5 mL) of the vasoconstrictor endothelin-1 (400 pmol/mL, AusPep, Australia) into the right sensorimotor cortex (0.5 and 2.0 mm anterior, 2.5 mm lateral relative to bregma, and 1.5 mm below the dura). 12 additional rats were used as unlesioned controls, receiving saline injections. At 6 days or 3 weeks after lesioning, animals received two intracortical injections (1 mL each) of hESC-derived cortical progenitor and/or SAP gels into the lesion site (above co-ordinates). Final concentration of implanted SAP gels was 10 mg/mL and total number of cells 100,000/rat.
Behavior
The modified staircase test (Winkler et al., 1999) was commenced 1 week after ET1 lesioning (T = 0 weeks, pre-graft) and repeated at 4, 8, 16, 24, and 36 weeks following implants. Rats were food-restricted for the 7 day test duration, placed in the staircase apparatus daily (Campden Instruments, UK), and pellets retrieved and eaten recorded over 20 min. Impaired (left) paw retrievals were expressed as a percentage of total (%L/L + R) and averaged over the last 3 test days. At T = 0 weeks, only animals capable of retrieving a minimum of 20 pellets with the unimpaired forepaw were included in the study, and only animals showing %33% of pellet retrievals with the impaired paw were deemed to have sufficient lesions of the motor cortex to warrant inclusion. Rotarod performance test was conducted in rats at 36 weeks following cells ± SAP implantation. Animals were placed on a horizontal, suspended, accelerating rotating rod (3-40 rpm) and the latency to fall (max 5 min) recorded, and each received three consecutive trials. Cylinder test was performed at 36 weeks post implantation. Animals were placed in a glass cylinder (20 cm diameter), and two observers recorded weight-bearing forepaw wall contacts (max 20 per animal, expressed as a percentage of impaired touches/total). Stepping test was performed as described previously (Olsson et al., 1995) . Rats were restrained by the experimenter, allowing them to make unilateral forepaw weight-bearing contact with the bench, and were assessed for their ability to make stepping adjustments with the paw when moved laterally over a 1 m distance. Number of steps made by weight-bearing forepaws was recorded in both the forehand and backhand direction, with testing repeated 3 times/day over 5 days.
Tissue Processing and Histology
The majority of animals were killed by an overdose of sodium pentobarbitone (100 mg/kg) and processed for immunohistochemistry, as previously described (Denham et al., 2012) . Primary antibodies: rabbit anti-5HT (1:1,000, Immunostar), rabbit anti-BRN2 (1:200, Santa Cruz), goat anti-choline acetyltransferase (1:100, Millipore), goat anti-doublecortin (1:400; Santa Cruz), rabbit anti-GFAP (1:200, Dako), chicken anti-GFP (1:1,000; Abcam), rabbit anti-GFP (1:20,000; Abcam), mouse rabbit anti-Ki67 (1:1,000, Novocastra), mouse anti-NEUN (1:100; R&D Systems), rabbit anti-OLIG2 (1:200, Millipore), rabbit anti-OTX2 (1:4,000, Millipore), mouse anti-PAX6 (1:50, Developmental Studies Hybridoma Bank [DSHB]), anti-rat endothelial cell antigen-1 (RECA-1, 1:500, Serotec), mouse anti-RIP (1:5,000, Millipore), goat anti-SOX2 (1:200; R&D), TBR1 (1:1,000, Millipore), tyrosine hydroxylase (TH, 1:800, Pel-Freez), mouse anti-vesicular glutamate transporter 1 (vGLUT, 1:200, Millipore, MAB5504).
Assessment of Host and Graft Tissue
Atrophy and neuronal cell loss within the host cortex were quantified in control and ET1-lesioned rats, immuno-labeled with NEUN, at 36 weeks after cell ± SAP implants. Ipsilateral cortical atrophy was quantified from a 1:12 series, spanning 2.7 mm rostral to 2.1 mm caudal to bregma (five sections, Figures  S1, related to 7) , and expressed as a percentage of control (saline injected) cortex. Volume was calculated from the sum of areas, section thickness, and interval, according to Cavalieri's principle.
NEUN cell loss was estimated from the two sections (0.8 and 1.7 mm rostral to bregma) ventro-lateral to the infarct core ( Figures 7D-7F , 7K, and 7L, see boxed insets). Stereological counts were made in the delineated area (1.5 3 1.5 mm) at regular pre-determined intervals (200 3 200 mm), within a counting frame (40 3 40 mm), and guard zones set at 1 mm, as previously described (Parish et al., 2001 ). PSC grafts were identified by GFP-labeling with volumetric assessments, cell counts (DAPI, NEUN, BRN2, and TBR1), and densities performed stereologically. Counts were made at the following pre-determined intervals (DAPI: 500 3 500 mm; NEUN: 400 3 400 mm; and TBR1 and BRN2: 280 3 280 mm) using counting frames of known areas (DAPI: 10 3 10 mm; NEUN: 20 3 20 mm; and TBR1 and BRN2: 30 3 30 mm). For all counts, the co-efficient of error (CE) and co-efficient of variance (CV) were calculated as estimates of precision and values of less than 0.1 were accepted (West et al., 1991) .
Graft innervation of host tissue was assessed in the motor cortex adjacent to the graft core ( Figures 4B and 4Bi ) and distal targets, the ipsilateral and contralateral entorhinal cortex ( Figures 4B, 4Biii, and 4Biv) . Leica LAS Image Analysis Software was used to estimate fiber density.
RECA-1 + vessel density was estimated from three sections/graft, with five sites (203 magnification) randomly sampled per section, as well as five sites within the host tissue, yet within 500 mm of the graft edge (identified by the GFP + /GFP À border), and indicative of the surrounding penumbra. Host vessel density was additionally assessed from the contralateral hemisphere of the saline-injected rats. Vessel density was expressed as the percentage total area covered by RECA-1 staining, averaged across the sampling sites. The diameter of 75 RECA-1 + vessel, randomly sampled from the three sections per graft, as well as in the surrounding host tissue, was quantified for each brain.
Electrophysiology
Coronal forebrain slices were prepared from cells and cells+SAP-implanted rats (n = 3/group) and whole-cell electrophysiology performed as previously described (Denham et al., 2012; Niclis et al., 2017a) . Biocytin (0.5%) was added to the recording pipette to fill neurons after recordings, enabling confirmation of graft origin (GFP + cytochemistry) and visualization of cell morphology ( Figures 6B and 6C ).
Statistical Analysis
Tests performed to identify significant changes between animal groups included: repeated-measures ANOVA, one-way ANOVAs with Tukey post hoc, and Student's t tests. Data represent mean ± SEM, with statistical significant set at a level of 0.05, *p < 0.05, **p < 0.01, and ***p < 0.001. 
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